Maxcyte (MXCT) Cash from Investing Activities (2020 - 2026)
Maxcyte has reported Cash from Investing Activities over the past 6 years, most recently at $9.7 million for Q4 2025.
- Quarterly Cash from Investing Activities rose 681.14% to $9.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.9 million through Dec 2025, up 274.13% year-over-year, with the annual reading at $25.9 million for FY2025, 274.13% up from the prior year.
- Cash from Investing Activities was $9.7 million for Q4 2025 at Maxcyte, up from $5.2 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $194.8 million in Q1 2022 and troughed at -$162.3 million in Q3 2021.
- The 5-year median for Cash from Investing Activities is $2.2 million (2023), against an average of -$6.6 million.
- Year-over-year, Cash from Investing Activities crashed 2939.61% in 2021 and then surged 1141.41% in 2022.
- A 5-year view of Cash from Investing Activities shows it stood at -$11.4 million in 2021, then plummeted by 136.88% to -$27.1 million in 2022, then surged by 84.72% to -$4.1 million in 2023, then skyrocketed by 59.77% to -$1.7 million in 2024, then soared by 681.14% to $9.7 million in 2025.
- Per Business Quant, the three most recent readings for MXCT's Cash from Investing Activities are $9.7 million (Q4 2025), $5.2 million (Q3 2025), and $1.5 million (Q2 2025).